title: Inter-relationship between testicular dysgenesis and Leydig cell function in the masculinization programming window in the rat.
abstract: The testicular dysgenesis syndrome (TDS) hypothesis proposes that maldevelopment of the testis, irrespective of cause, leads to malfunction of the somatic (Leydig, Sertoli) cells and consequent downstream TDS disorders. Studies in rats exposed in utero to di(n-butyl) phthalate (DBP) have strongly supported the TDS concept, but so far no direct evidence has been produced that links dysgenesis per se to somatic cell dysfunction, in particular to androgen production/action during the 'masculinization programming window' (MPW; e15.5-e18.5). Normal reproductive tract development and anogenital distance (AGD) are programmed within the MPW, and TDS disorders arise because of deficiencies in this programming. However, DBP-induced focal testicular dysgenesis (Leydig cell aggregation, ectopic Sertoli cells, malformed seminiferous cords) is not evident until after the MPW. Therefore, we used AGD as a read-out of androgen exposure in the MPW, and investigated if this measure was related to objectively quantified dysgenesis (Leydig cell aggregation) at e21.5 in male fetuses exposed to vehicle, DBP (500 or 750 mg/kg/day) or the synthetic glucocorticoid dexamethasone (Dex; alone or plus DBP-500) from e15.5-e18.5 (MPW), e13.5-e20.5 or e19.5-e20.5 (late window). Dysgenesis was found only in animals exposed to DBP during the MPW, and was negatively correlated (R² = -0.5) with AGD at e21.5 and at postnatal day 8, irrespective of treatment period. Dysgenesis was also negatively correlated (R² = -0.5) with intratesticular testosterone (ITT) at e21.5, but only when treatments in short windows (MPW, late window) were excluded; the same was true for correlation between AGD and ITT. We conclude that AGD, reflecting Leydig cell function solely within the MPW, is strongly related to focal dysgenesis. Our results point to this occurring because of a common early mechanism, targeted by DBP that determines both dysgenesis and early (during the MPW) fetal Leydig cell dysfunction. The findings provide strong validation of the TDS hypothesis.
authors.affiliation: MRC Centre for Reproductive Health, The University of Edinburgh, Edinburgh, United Kingdom. s.vandendriesche@ed.ac.uk
authors.forename: Sander
authors.initials: S
authors.lastname: van den Driesche
authors.forename: Petros
authors.initials: P
authors.lastname: Kolovos
authors.forename: Sophie
authors.initials: S
authors.lastname: Platts
authors.forename: Amanda J
authors.initials: AJ
authors.lastname: Drake
authors.forename: Richard M
authors.initials: RM
authors.lastname: Sharpe
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D003993:Dibutyl Phthalate; D004622:Embryo, Mammalian / Q000378:metabolism / Q000473:pathology; D005260:Female; D005333:Fetus / Q000378:metabolism / Q000473:pathology; D006059:Gonadal Dysgenesis / Q000378:metabolism / Q000473:pathology*; D007150:Immunohistochemistry; D007985:Leydig Cells / Q000378:metabolism / Q000473:pathology*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D013733:Testicular Diseases / Q000378:metabolism / Q000473:pathology*; D013737:Testis / Q000002:abnormalities / Q000196:embryology / Q000378:metabolism / Q000473:pathology; D013739:Testosterone / Q000378:metabolism
chemical_list: D003993:Dibutyl Phthalate; D013739:Testosterone